NDRA (STOCKS)
ENDRA Life Sciences Inc. Common Stock
$3.590000
-0.150000 (-4.01%)
Prev close: $3.740000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Alexander Y. Tokman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4.15M
- Employees
- 16
- P/E (TTM)
- -0.27
- P/B (TTM)
- 17.13
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $8.44M |
| Research and Development | $1.98M |
| Other Operating Expenses | $6.41M |
| Operating Income/Loss | -$8.44M |
| Income/Loss From Continuing Operations After Tax | -$8.01M |
| Income/Loss From Continuing Operations Before Tax | -$8.01M |
| Net Income/Loss | -$8.01M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$8.01M |
| Net Income/Loss Available To Common Stockholders, Basic | -$8.01M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Diluted Earnings Per Share | $19.52 |
| Diluted Average Shares | 791,724 |
| Assets | $1.96M |
| Current Assets | $1.05M |
| Inventory | $0.00 |
| Prepaid Expenses | $254.67K |
| Other Current Assets | $794.04K |
| Noncurrent Assets | $915.40K |
| Fixed Assets | $52.63K |
| Non-current Prepaid Expenses | $365.42K |
| Other Non-current Assets | $497.35K |
| Liabilities | $1.79M |
| Current Liabilities | $800.31K |
| Accounts Payable | $252.49K |
| Wages | $152.56K |
| Other Current Liabilities | $395.26K |
| Noncurrent Liabilities | $992.42K |
| Equity | $171.38K |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $171.38K |
| Liabilities And Equity | $1.96M |
| Net Cash Flow From Operating Activities | -$5.09M |
| Net Cash Flow From Operating Activities, Continuing | -$5.09M |
| Net Cash Flow From Investing Activities | -$17.28K |
| Net Cash Flow From Investing Activities, Continuing | -$17.28K |
| Net Cash Flow From Financing Activities | $1.15M |
| Net Cash Flow From Financing Activities, Continuing | $1.15M |
| Net Cash Flow | -$3.95M |
| Net Cash Flow, Continuing | -$3.95M |
| Comprehensive Income/Loss | -$8.01M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$8.01M |
| Other Comprehensive Income/Loss | $0.00 |